https://bpcruk.com/https://bpcruk.com/01-existing-articles/https://bpcruk.com/02-set-a-new-articles-of-association/https://bpcruk.com/03-blackline-of-set-a-new-articles-v-existing-articles/https://bpcruk.com/04-set-b-new-articles-of-association/https://bpcruk.com/05-blackline-of-set-b-new-articles-v-existing-articles/https://bpcruk.com/06-blackline-investment-policy-2018-prospectus-vs-proposed-investment-policy/https://bpcruk.com/07-bpcr-circular-10-09-21/https://bpcruk.com/22-september-2025-hy-earnings-presentation/https://bpcruk.com/2017-pfic-annual-information-statement/https://bpcruk.com/2018-pfic-annual-information-statements/https://bpcruk.com/2019-pfic-annual-information-statements/https://bpcruk.com/2020-pfic-annual-information-statement-biopharma-credit-plc/https://bpcruk.com/2020-pfic-annual-information-statement-bpcr-ongdapa-limited/https://bpcruk.com/2021-pfic-annual-information-statement-biopharma-credit-plc/https://bpcruk.com/2021-pfic-annual-information-statement-bpcr-ongdapa-limited/https://bpcruk.com/2022-pfic-annual-information-statement-biopharma-credit-plc/https://bpcruk.com/2022-pfic-annual-information-statement-bpcr-ongdapa-limited/https://bpcruk.com/2023-pfic-annual-information-statement-biopharma-credit-plc/https://bpcruk.com/2023-pfic-annual-information-statement-bpcr-ongdapa-limited/https://bpcruk.com/2024-pfic-annual-information-statement-bpcr-ongdapa-limited/https://bpcruk.com/2024-pfic-annual-information-statement/https://bpcruk.com/2025-24-march-2026-earnings-presentation/https://bpcruk.com/2025-pfic-annual-information-statement-2/https://bpcruk.com/2025-pfic-annual-information-statement/https://bpcruk.com/about-us/https://bpcruk.com/additional-article-23-disclosures/https://bpcruk.com/announcement-extension-tender-offers/https://bpcruk.com/announcement-results-tender-offer/https://bpcruk.com/annual-report-2021-web/https://bpcruk.com/annual-report-2024/https://bpcruk.com/annual-report-2025/https://bpcruk.com/audit-and-risk-committee-terms-of-reference/https://bpcruk.com/biopharma-annual-report-2017/https://bpcruk.com/biopharma-annual-report-2019/https://bpcruk.com/biopharma-annual-report-2020/https://bpcruk.com/biopharma-credit-5-march-2019-earnings-presentation/https://bpcruk.com/biopharma-credit-10-march-2020-earnings-presentation/https://bpcruk.com/biopharma-credit-16-march-2021-earnings-presentation/https://bpcruk.com/biopharma-credit-16-september-2020-hy-earnings-presentation/https://bpcruk.com/biopharma-credit-22-march-2022-earnings-presentation/https://bpcruk.com/biopharma-credit-22-march-2023-earnings-presentation/https://bpcruk.com/biopharma-credit-27-march-2024-earnings-presentation/https://bpcruk.com/biopharma-credit-27-september-2023-hy-earnings-presentation/https://bpcruk.com/biopharma-credit-2018-half-yearly-presentation-september-27-2018/https://bpcruk.com/biopharma-credit-annual-report-2018/https://bpcruk.com/biopharma-credit-annual-report-2022/https://bpcruk.com/biopharma-credit-annual-report-2023/https://bpcruk.com/biopharma-credit-circular-16-march-2018/https://bpcruk.com/biopharma-credit-half-yearly-presentation-september-2019/https://bpcruk.com/biopharma-credit-half-yearly-report-2018/https://bpcruk.com/biopharma-credit-investor-presentation-1-september-2023/https://bpcruk.com/biopharma-credit-investor-presentation-19-april-2023/https://bpcruk.com/biopharma-credit-investor-presentation-december-2020/https://bpcruk.com/biopharma-credit-investor-presentation-february-10-2020/https://bpcruk.com/biopharma-credit-investor-presentation-february-2022/https://bpcruk.com/biopharma-credit-investor-presentation-january-2022/https://bpcruk.com/biopharma-credit-investor-presentation-june-12-2019/https://bpcruk.com/biopharma-credit-investor-presentation-june-2021/https://bpcruk.com/biopharma-credit-investor-presentation-june-2022/https://bpcruk.com/biopharma-credit-investor-presentation-november-2022/https://bpcruk.com/biopharma-credit-investor-presentation-october-10-2019/https://bpcruk.com/biopharma-credit-investor-presentation-results/https://bpcruk.com/biopharma-credit-investor-presentation-september-13-2018/https://bpcruk.com/biopharma-credit-investor-presentation-september-2021/https://bpcruk.com/biopharma-credit-investor-presentation-september-2022/https://bpcruk.com/biopharma-credit-investor/https://bpcruk.com/biopharma-credit-notice-of-agm-2024/https://bpcruk.com/biopharma-credit-plc-half-yearly-report-2017/https://bpcruk.com/biopharma-credit-plc-intention-float-announcement/https://bpcruk.com/biopharma-credit-plc-investor-presentation-december-2017/https://bpcruk.com/biopharma-credit-plc-investor-update-april-2017/https://bpcruk.com/biopharma-credit-plc-investor-update-april-2018/https://bpcruk.com/biopharma-credit-plc-investor-update-april-2019/https://bpcruk.com/biopharma-credit-plc-investor-update-april-2020/https://bpcruk.com/biopharma-credit-plc-investor-update-april-2021/https://bpcruk.com/biopharma-credit-plc-investor-update-april-2022/https://bpcruk.com/biopharma-credit-plc-investor-update-april-2023/https://bpcruk.com/biopharma-credit-plc-investor-update-april-2024/https://bpcruk.com/biopharma-credit-plc-investor-update-august-2017/https://bpcruk.com/biopharma-credit-plc-investor-update-august-2018/https://bpcruk.com/biopharma-credit-plc-investor-update-august-2019/https://bpcruk.com/biopharma-credit-plc-investor-update-august-2020/https://bpcruk.com/biopharma-credit-plc-investor-update-august-2021/https://bpcruk.com/biopharma-credit-plc-investor-update-august-2022/https://bpcruk.com/biopharma-credit-plc-investor-update-august-2023/https://bpcruk.com/biopharma-credit-plc-investor-update-december-2017/https://bpcruk.com/biopharma-credit-plc-investor-update-december-2018/https://bpcruk.com/biopharma-credit-plc-investor-update-december-2019/https://bpcruk.com/biopharma-credit-plc-investor-update-december-2020/https://bpcruk.com/biopharma-credit-plc-investor-update-december-2021/https://bpcruk.com/biopharma-credit-plc-investor-update-december-2022/https://bpcruk.com/biopharma-credit-plc-investor-update-december-2023/https://bpcruk.com/biopharma-credit-plc-investor-update-february-2018/https://bpcruk.com/biopharma-credit-plc-investor-update-february-2019/https://bpcruk.com/biopharma-credit-plc-investor-update-february-2020/https://bpcruk.com/biopharma-credit-plc-investor-update-february-2021/https://bpcruk.com/biopharma-credit-plc-investor-update-february-2022/https://bpcruk.com/biopharma-credit-plc-investor-update-february-2023/https://bpcruk.com/biopharma-credit-plc-investor-update-february-2024/https://bpcruk.com/biopharma-credit-plc-investor-update-january-2018/https://bpcruk.com/biopharma-credit-plc-investor-update-january-2019/https://bpcruk.com/biopharma-credit-plc-investor-update-january-2020/https://bpcruk.com/biopharma-credit-plc-investor-update-january-2021/https://bpcruk.com/biopharma-credit-plc-investor-update-january-2022/https://bpcruk.com/biopharma-credit-plc-investor-update-january-2023/https://bpcruk.com/biopharma-credit-plc-investor-update-january-2024/https://bpcruk.com/biopharma-credit-plc-investor-update-july-2017/https://bpcruk.com/biopharma-credit-plc-investor-update-july-2018/https://bpcruk.com/biopharma-credit-plc-investor-update-july-2019/https://bpcruk.com/biopharma-credit-plc-investor-update-july-2020/https://bpcruk.com/biopharma-credit-plc-investor-update-july-2021/https://bpcruk.com/biopharma-credit-plc-investor-update-july-2022/https://bpcruk.com/biopharma-credit-plc-investor-update-july-2023/https://bpcruk.com/biopharma-credit-plc-investor-update-june-2017/https://bpcruk.com/biopharma-credit-plc-investor-update-june-2018/https://bpcruk.com/biopharma-credit-plc-investor-update-june-2019/https://bpcruk.com/biopharma-credit-plc-investor-update-june-2020/https://bpcruk.com/biopharma-credit-plc-investor-update-june-2021/https://bpcruk.com/biopharma-credit-plc-investor-update-june-2022/https://bpcruk.com/biopharma-credit-plc-investor-update-june-2023/https://bpcruk.com/biopharma-credit-plc-investor-update-march-2018/https://bpcruk.com/biopharma-credit-plc-investor-update-march-2019/https://bpcruk.com/biopharma-credit-plc-investor-update-march-2020/https://bpcruk.com/biopharma-credit-plc-investor-update-march-2021/https://bpcruk.com/biopharma-credit-plc-investor-update-march-2022/https://bpcruk.com/biopharma-credit-plc-investor-update-march-2023/https://bpcruk.com/biopharma-credit-plc-investor-update-march-2024/https://bpcruk.com/biopharma-credit-plc-investor-update-may-2017/https://bpcruk.com/biopharma-credit-plc-investor-update-may-2018/https://bpcruk.com/biopharma-credit-plc-investor-update-may-2019/https://bpcruk.com/biopharma-credit-plc-investor-update-may-2020/https://bpcruk.com/biopharma-credit-plc-investor-update-may-2021/https://bpcruk.com/biopharma-credit-plc-investor-update-may-2022/https://bpcruk.com/biopharma-credit-plc-investor-update-may-2023/https://bpcruk.com/biopharma-credit-plc-investor-update-november-2017/https://bpcruk.com/biopharma-credit-plc-investor-update-november-2018/https://bpcruk.com/biopharma-credit-plc-investor-update-november-2019/https://bpcruk.com/biopharma-credit-plc-investor-update-november-2020/https://bpcruk.com/biopharma-credit-plc-investor-update-november-2021/https://bpcruk.com/biopharma-credit-plc-investor-update-november-2022/https://bpcruk.com/biopharma-credit-plc-investor-update-november-2023/https://bpcruk.com/biopharma-credit-plc-investor-update-october-2017/https://bpcruk.com/biopharma-credit-plc-investor-update-october-2018/https://bpcruk.com/biopharma-credit-plc-investor-update-october-2019/https://bpcruk.com/biopharma-credit-plc-investor-update-october-2020/https://bpcruk.com/biopharma-credit-plc-investor-update-october-2021/https://bpcruk.com/biopharma-credit-plc-investor-update-october-2022/https://bpcruk.com/biopharma-credit-plc-investor-update-september-2017/https://bpcruk.com/biopharma-credit-plc-investor-update-september-2018/https://bpcruk.com/biopharma-credit-plc-investor-update-september-2019/https://bpcruk.com/biopharma-credit-plc-investor-update-september-2020/https://bpcruk.com/biopharma-credit-plc-investor-update-september-2021/https://bpcruk.com/biopharma-credit-plc-investor-update-september-2022-2/https://bpcruk.com/biopharma-credit-plc-investor-update-september-2023-2/https://bpcruk.com/biopharma-credit-plc-investor-update-september-2023/https://bpcruk.com/biopharma-credit-plc-prospectus/https://bpcruk.com/biopharma-credit-presentation-february-2018/https://bpcruk.com/biopharma-credit-prospectus-14-march-2018/https://bpcruk.com/blog/https://bpcruk.com/bpcr-amended-and-restated-articles-of-association/https://bpcruk.com/bpcr-attendance-card-of-annual-general-meeting-19-june-2019/https://bpcruk.com/bpcr-half-yearly-report-2021/https://bpcruk.com/bpcr-letter-from-the-auditor/https://bpcruk.com/bpcr-notice-annual-general-meeting-29-june-2018/https://bpcruk.com/bpcr-notice-of-annual-general-meeting-9-june-2022/https://bpcruk.com/bpcr-notice-of-annual-general-meeting-19-june-2019/https://bpcruk.com/bpcr-notice-of-annual-general-meeting-25-june-2020/https://bpcruk.com/bpcr-notice-of-annual-general-meeting/https://bpcruk.com/bpcr-notice-of-general-meeting-24-june-2021/https://bpcruk.com/bpcr-notice-of-general-meeting-28-december-2023/https://bpcruk.com/category/corporate-governance/https://bpcruk.com/category/dividends/https://bpcruk.com/category/esg/https://bpcruk.com/category/fact-sheets/https://bpcruk.com/category/presentations/https://bpcruk.com/category/reports/https://bpcruk.com/category/shareholder-information/https://bpcruk.com/category/tax-documents/https://bpcruk.com/contact/https://bpcruk.com/currency-election-form/https://bpcruk.com/esg/https://bpcruk.com/glossary/https://bpcruk.com/half-year-report-2024/https://bpcruk.com/half-yearly-report-2019/https://bpcruk.com/half-yearly-report-2020/https://bpcruk.com/half-yearly-report-2022/https://bpcruk.com/half-yearly-report-2023/https://bpcruk.com/half-yearly-report-2025/https://bpcruk.com/home/https://bpcruk.com/imperial-final-results-issue/https://bpcruk.com/investment-strategy-portfolio/https://bpcruk.com/investor-materials/https://bpcruk.com/investor-presentation-5-march-2025/https://bpcruk.com/investor-presentation-7-june-2024/https://bpcruk.com/investor-presentation-7-november-2024/https://bpcruk.com/investor-presentation-june-2025/https://bpcruk.com/investor-presentation-march-2026/https://bpcruk.com/investor-presentation-september-2025/https://bpcruk.com/investor-update-april-2025/https://bpcruk.com/investor-update-august-2024/https://bpcruk.com/investor-update-august-2025/https://bpcruk.com/investor-update-december-2024/https://bpcruk.com/investor-update-december-2025/https://bpcruk.com/investor-update-february-2025/https://bpcruk.com/investor-update-february-2026/https://bpcruk.com/investor-update-january-2025/https://bpcruk.com/investor-update-january-2026/https://bpcruk.com/investor-update-july-2024/https://bpcruk.com/investor-update-july-2025/https://bpcruk.com/investor-update-june-2024/https://bpcruk.com/investor-update-june-2025/https://bpcruk.com/investor-update-march-2025/https://bpcruk.com/investor-update-may-2024/https://bpcruk.com/investor-update-may-2025/https://bpcruk.com/investor-update-november-2024/https://bpcruk.com/investor-update-november-2025/https://bpcruk.com/investor-update-october-2024/https://bpcruk.com/investor-update-october-2025/https://bpcruk.com/investor-update-september-2024/https://bpcruk.com/investor-update-september-2025/https://bpcruk.com/key-information-document/https://bpcruk.com/news-categories/news-category/https://bpcruk.com/news/news-article-1/https://bpcruk.com/news/news-article-2/https://bpcruk.com/news/news-article-3/https://bpcruk.com/news/news-article-4/https://bpcruk.com/notice-of-agm-2023/https://bpcruk.com/notice-of-agm/https://bpcruk.com/pharmakons-esg-policy/https://bpcruk.com/privacy-policy/https://bpcruk.com/regulatory-news/https://bpcruk.com/search/